U.S. Hotel and Resort REITs Stock News

If you are wondering whether Harmonic's current share price reflects its true worth, you are not alone. The stock has drawn attention from investors trying to work out if it is now cheap or still priced for caution. The share price closed at US$9.37 recently, with returns of a 5.6% decline over 7 days, 9.4% decline over 30 days, 6.5% decline year to date, 9.0% decline over 1 year and 25.8% decline over 3 years, compared with a 14.3% gain over 5 years. Recent news coverage has focused on...

If you are wondering whether SharkNinja at around US$101.68 is giving you fair value or asking too much, you are not alone. That question is exactly what this article aims to unpack. The stock has seen a 10.8% decline over the last 7 days and a 14.3% decline over the last 30 days, although it still shows a 16.9% return over the past year. This can change how investors view both its potential and its risks. Recent coverage has focused on SharkNinja as a branded consumer products company...

Viavi Solutions (VIAV) has introduced two key products, the FTH-DAS fiber test head with embedded AI and the TestCenter D2 1.6T Appliance, targeting AI data centers and critical infrastructure monitoring needs. See our latest analysis for Viavi Solutions. Despite a 1 day share price return decline of 1.10% and a 7 day share price return decline of 4%, Viavi’s recent AI focused product launches sit against a 30 day share price return of 8.89% and a 90 day share price return of 65.33%. The 1...

If you are wondering whether WESCO International at around US$257.69 is still offering value after a strong run, you are not alone. The stock has pulled back with an 8.6% decline over the last week and a 9.8% decline over the last month, even though the 1 year return sits at 64.4% and the 5 year return at 196.2%. Recent attention on WESCO International has focused on its role in capital goods and electrical distribution, as investors reassess what they are willing to pay for companies in...

If you are wondering whether McEwen at around US$24.43 is priced attractively or already reflects most of its potential, this article walks through the key numbers that matter. The stock has seen a 1% gain over the last week, a 10.5% decline over the last 30 days, and returns of 30.8% year to date and 227.5% over the past year, so recent moves may have shifted how investors view both its potential and its risks. Recent coverage has focused on McEwen as a precious metals name in the...

If you are wondering whether Matador Resources at around US$56.16 is offering good value or getting ahead of itself, this article will walk through the key numbers that matter. The stock has posted returns of 2.1% over the last 7 days, 19.7% over the last 30 days, 29.5% year to date and 23.4% over the last year, with a 3 year return of 30.9% and a 5 year return of 168.2%. Recent attention on Matador Resources has been shaped by ongoing sector wide interest in energy producers and investors...

Atlassian (TEAM) has moved to the center of investor attention after announcing a restructuring that will cut about 10% of its workforce and coincide with a change in the chief technology officer role. See our latest analysis for Atlassian. The restructuring news arrives after a steep reset in sentiment, with the 30 day share price return at a 21.07% decline and the year to date share price return at a 52.61% decline. The 1 year total shareholder return is a 64.74% loss, suggesting momentum...

Recent commentary on Origin Bancorp highlights that, despite a strong six-month performance versus the broader market, analysts are increasingly focused on the bank’s modest long-term revenue growth, below-standard net interest margin, and limited expected tangible book value per share expansion. This contrast between recent share outperformance and concerns about underlying profitability and balance sheet growth raises questions about how durable Origin Bancorp’s current profile really...

If you are wondering whether Banc of California is attractively priced at around US$16.80, you are not alone. This article looks at what that tag might really imply for long term investors. The stock has seen mixed recent returns, with a 6% decline over the last week and an 18.7% decline over the last 30 days, although the 1 year return stands at 28.5%. Recent headlines around Banc of California have focused on its position within the US banking sector and how investors are reassessing...

Adecoagro SA recently reported its fourth-quarter and full-year 2025 results, highlighting revenue growth but continued margin pressure across its farming, sugar, ethanol, and dairy businesses following a difficult third quarter. The results also drew attention to how the Profertil acquisition and a US$300 million share offering may reshape Adecoagro’s ability to restore and sustain profitability. Next, we’ll examine how Adecoagro’s effort to rebuild margins after its recent results could...

Rithm Capital stock overview Rithm Capital (RITM) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months despite positive recent revenue and net income figures. See our latest analysis for Rithm Capital. At a share price of US$9.60, Rithm Capital has seen pressure build in the short term, with a 30 day share price return of a 10.03% decline and a year to date share price return of a 12.57% decline...

If you are wondering whether Bloom Energy's share price actually lines up with its underlying value, or if the story has run ahead of the numbers, this article will walk through what the data currently suggests. The stock last closed at US$157.17, with returns of 5.7% over 30 days, a 59.3% gain year to date, and very large gains over 1 year and 3 years, which can change how investors think about both upside potential and risk. Recent headlines have focused on Bloom Energy's role in clean...

In March 2026, Compass Therapeutics, Inc. filed a shelf registration to offer up to 11,132,940 shares of common stock, valued at about US$62.23 million, in connection with its employee stock ownership plans. This move follows the company’s recently reported 2025 net loss of US$66.49 million, highlighting an ongoing need to support operations through potential equity financing. We will now examine how Compass Therapeutics’ sizeable shelf registration for an employee-related equity offering...

BETA Technologies (BETA) is back in focus after Surf Air Mobility agreed to buy 25 ALIA CTOL aircraft, with options for up to 75 more, to launch commercial electric passenger services starting in Hawaii. See our latest analysis for BETA Technologies. The Surf Air Mobility deal follows a busy few weeks that included full year 2025 results, updated 2026 revenue guidance and selection for seven of eight federal eVTOL Integration Pilot Programs. Despite these developments, the share price remains...

Instacart parent Maplebear (NasdaqGS:CART) has partnered with Fareway to roll out an upgraded digital grocery experience using Storefront Pro and the Instacart Marketplace. The collaboration introduces no markup pickup orders and targets higher e commerce usage across Fareway’s 140+ stores in the Midwest. The partnership expands Maplebear’s enterprise commerce platform and extends its reach with a sizable regional grocer. For investors watching NasdaqGS:CART at a share price of $37.71, this...

Ormat Technologies has now begun commercial operations at its 80MW/320MWh Shirk battery storage facility in Visalia, California and, separately, amended long-term power purchase agreements for 15MW of output from its Casa Diablo-IV geothermal plant, extending these contracts to 2037 with higher pricing effective from October 2026. Together, the new battery storage project and richer, longer geothermal contracts deepen Ormat’s contracted revenue base in California while maximizing available...

SolarEdge Technologies (SEDG) has drawn attention after recent price moves left the stock with a 1 year total return of 134% and a past 3 months return of 19%, prompting closer scrutiny of its fundamentals. See our latest analysis for SolarEdge Technologies. The latest share price of US$35.19 sits against a mixed backdrop, with a 19.2% 3 month share price return but a 3 year total shareholder return that is still down 87.7%. This suggests recent momentum follows a much larger earlier...

Unum Group (UNM) is back on investors’ radar after recent share price swings, with short term returns mixed across the past week, month, and past 3 months. This has prompted closer attention to its fundamentals. See our latest analysis for Unum Group. At a share price of US$72.69, Unum Group’s recent moves include a 1-day share price return of 0.25% and a 30-day share price return of 1.32%. The year to date share price return of 5.88% and 1-year total shareholder return of 3.57% sit against a...

Hertz Global Holdings (HTZ) is drawing fresh attention after reporting its first profitable quarter in two years, with 84% vehicle utilization, even as a recent analyst price target cut highlights ongoing sector pressures. See our latest analysis for Hertz Global Holdings. Despite the return to quarterly profitability and solid 84% utilization, the share price has been weak, with a 30-day share price return of 25.19% decline and a year to date share price return of 25.48% decline. Over a...

How CNO Financial Group Stock Has Been Moving CNO Financial Group (CNO) has seen its share price slip recently, with a 0.4% decline at the latest close to $39.77, alongside negative returns over the week, month, and past 3 months. Over the past year, however, the stock shows a 4.3% total return. Longer horizons such as 3 and 5 years reflect higher cumulative gains, which some investors may weigh against the more recent pullback. See our latest analysis for CNO Financial Group. For CNO...

Event overview and why Universal (UVV) is in focus Universal (UVV) is back on investors’ radar after management acknowledged that tobacco oversupply is affecting its core tobacco operations, while its ingredients diversification business recorded an operating loss in Q3 FY2026. To address these pressures, the company expanded its credit facility by US$250 million and appointed a new CFO. These steps reshape its financial flexibility and leadership profile at a time when both business segments...

Celcuity (NasdaqCM:CELC) reported positive efficacy and safety results from its Phase 3 VIKTORIA-1 trial of gedatolisib in advanced breast cancer, published in the Journal of Clinical Oncology. The trial data showed a substantial reduction in the risk of disease progression or death for patients treated with gedatolisib-based regimens. The FDA has accepted Celcuity's new drug application for gedatolisib and granted Priority Review, with a PDUFA decision date set for July 2026. Celcuity...

CSG Systems International (NasdaqGS:CSGS) has agreed to be acquired by NEC Corporation. The deal marks a change in ownership that is expected to reshape how the company is positioned within the broader technology and communications sector. The acquisition terms center on CSG Systems International's current share price of $79.79 and its existing shareholder base. For current shareholders, this news follows a period in which NasdaqGS:CSGS has recorded a 36.7% return over 1 year, 64.1% over 3...

Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent for prostate cancer, and tentative FDA approval for a radioequivalent version of LUTATHERA for somatostatin receptor–positive neuroendocrine tumors. These approvals build directly on the clinical evidence and commercial footprint of PYLARIFY, potentially strengthening Lantheus’s position across prostate and neuroendocrine tumor imaging while improving manufacturing...